ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FGEN FibroGen Inc

0.9843
-0.0857 (-8.01%)
After Hours
Last Updated: 16:38:32
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,164,654
Bid Price 0.985
Ask Price 1.04
News (1)
Day High 1.0976

Low
0.3333

52 Week Range

High
20.28

Day Low 0.9327
Company Name Stock Ticker Symbol Market Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0857 -8.01% 0.9843 16:38:32
Open Price Low Price High Price Close Price Prev Close
1.06 0.9327 1.0976 0.9843 1.07
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,250 2,164,654 $ 0.9999575 $ 2,164,562 - 0.3333 - 20.28
Last Trade Time Type Quantity Stock Price Currency
16:29:31 formt 250 $ 1.05 USD

FibroGen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
96.8M 98.77M - 147.75M -284.23M -2.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

FibroGen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FGEN Message Board. Create One! See More Posts on FGEN Message Board See More Message Board Posts

Historical FGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.301.330.93271.161,154,576-0.3157-24.28%
1 Month2.462.680.93271.571,844,926-1.48-59.99%
3 Months1.752.930.93271.992,359,300-0.7657-43.75%
6 Months0.53812.930.33331.412,276,8870.446282.92%
1 Year20.2820.280.33332.612,906,921-19.30-95.15%
3 Years21.8130.12490.33337.671,616,658-20.83-95.49%
5 Years48.1457.20880.333315.341,291,161-47.16-97.96%

FibroGen Description

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Your Recent History

Delayed Upgrade Clock